The Global Glucagon-like peptide-1 (GLP-1) analogs Market Is Estimated To Witness High Growth Owing To the increasing prevalence of diabetes and the rising demand for better treatment options
The market is estimated to be valued at US$ 11.87 billion in 2023 and is expected to exhibit a CAGR
Read More